Endocannabinoids mediate muscarine-induced synaptic depression at the vertebrate neuromuscular junction.

Newman, Zachary; Malik, Priya; Wu, Tse-Yu; Ochoa, Christopher; Watsa, Nayantara; Lindgren, Clark

Newman, Zachary; Malik, Priya; Wu, Tse-Yu; Ochoa, Christopher; Watsa, Nayantara; Lindgren, Clark.

Affiliation

Newman Z; Department of Biology, Grinnell College, Grinnell, IA 50112, USA.

Eur J Neurosci ; 25(6): 1619-30, 2007 Mar.

Article in En | MEDLINE | ID: mdl-17408433

Subject(s)

Cannabinoid Receptor Modulators/metabolism; Endocannabinoids; Inhibitory Postsynaptic Potentials/drug effects; Muscarine/pharmacology; Muscarinic Agonists/pharmacology; Neuromuscular Junction/drug effects; Animals; Arachidonic Acids/pharmacology; Calcium/metabolism; Drug Interactions; Enzyme Inhibitors/pharmacology; Lizards; Models, Biological; Morpholines/pharmacology; Neuromuscular Junction/metabolism; Piperidines/pharmacology; Pyrazoles/pharmacology; Receptor, Cannabinoid, CB1/agonists; Receptor, Cannabinoid, CB1/antagonists & inhibitors; Receptor, Cannabinoid, CB1/metabolism

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Muscarinic Agonists / Endocannabinoids / Inhibitory Postsynaptic Potentials / Cannabinoid Receptor Modulators / Muscarine / Neuromuscular Junction Type of study: Prognostic_studies Limits: Animals Language: En Journal: Eur J Neurosci Journal subject: NEUROLOGIA Year: 2007 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google